Plenary Agenda 

Tuesday|5 March 2024 | DAY ONE 

Location: Grand Ballroom II & III

_______________________________________________________________

7:00-8:00 | Registration

8:00-8:30 | Welcome Remarks

• Masters of Ceremony 
• Speakers
  • Dr. Youngmee Jee - Commissioner, Korea Disease Control and Prevention Agency
  • Mr. Taisuke Mibae - Minister and Deputy chief of Mission, Embassy of Japan 
  • Mr. Andrew Herrup, Minister Counselor for Economic Affairs, Embassy of the United States of America
  • Dr. Hiroshi Kiyono - Distinguished Professor, Future Medicine Education and Research Organization, Chiba University/Department of Human Mucosal Vaccinology, Chiba University Hospital - Japan / Japanese Delegation Chair, USJCMSP
  • Dr. Diane E. Griffin - University Distinguished Service Professor, Johns Hopkins Bloomberg School of Public Health, USA - U.S Delegation Chair, USJCMSP

8:30-9:00 | Shimao-Takeda Lectureship

• Introduced by Dr. Hiroshi Kiyono
• Dr. Yoshihiro Kawaoka - The University of Tokyo / National Center for Global Health and Medicine / University of Wisconsin School of Veterinary Medicine 

9:00-9:30 | La Montagne-Heilman Lectureship

• Introduced by Dr. Diane E Griffin
• Dr. Daved Fremont - Washington University in St. Louis

_______________________________________________________________

9:30-9:45 | Coffee Break 

_______________________________________________________________

SESSION ONE: AI/Data Science-Based Prediction of Emerging Infection

Moderators: Dr. Kei Sato - The University of Tokyo & Dr. Richard Kuhn, Purdue University

Rapporteurs: Dr. Conrad Mallia, NIAID 

9:45-10:05 | Real-time causal inference of COVID-19 interventions using counterfactual reproduction number | Dr. Hiroshi Nishiura - Kyoto University

10:05-10:10 | Q&A

10:10-10:30 | Evolution of SARS-CoV-2: Now and Then | Dr. Kei Sato - University of Tokyo

10:30-10:35 | Q&A

10:35-10:55 | Design of New Protein Functions Using Deep Learning | Dr. David Baker - University of Washington - Virtual

10:55-11:00 | Q&A

11:00-11:20 | Contributions to public health policies through data-driven mathematical modeling during the COVID-19 pandemic and future roles in this field | Dr. Eunok Jung - Konkuk University

11:20-11:25 | Q&A

11:25-11:45 | Data Science-based Prediction of Emerging Infections, with SARS-CoV-2 as an Example | Dr. Bette Korber - New Mexico Consortium - Virtual

11:45-11:50 | Q&A

_______________________________________________________________

12:00-13:30 | Lunch break and Poster Session

_______________________________________________________________

SESSION TWO: Vaccine Science and Technology

Moderators: Dr. Ken J. Ishii - The University of Tokyo & Dr. Woo Joo Kim - Korea University

Rapporteurs: Dr. Hideki Ueno - Kyoto University & Dr. Erik Stemmy, NIAID, USA

13:30-13:50 | Department of Bio-medical Science and Engineering, Konkuk University, Seoul, Republic of Korea | Dr. Young Bong Kim - Konkuk University

13:50-13:55 | Q&A

13:55-14:15 | Development of vaccines based on a replication-incompetent Ebola virus | Dr. Tokiko Watanabe - Osaka University 

14:15-14:20 | Q&A

14:20-14:40 | Integrated Organ Immunity: A Path to a Universal Vaccine | Dr. Bali Pulendran - Stanford University

14:40-14:45 | Q&A

14:45-15:05 | Flagellin: A Versatile Engineerable Mucosal Vaccine Adjuvant | Dr. Joon Rhee - Chonnam National University Medical School

15:05-15:10 | Q&A

15:10-15:30 | From Need to Impact: Cholera Vaccine Development at IVI | Dr. Jerome Kim - International Vaccine Institute

15:30-15:35 | Q&A

_______________________________________________________________

15:35-15:50 |Break 

_______________________________________________________________

SESSION THREE: Broad Immunity Against Pathogens

Moderators: Dr. Tatsuya Kanto - National Center for Global Health and Medicine

Rapporteurs: Dr. Masanori Isogawa - National Institute of Infectious Diseases & Conrad Mallia - National Institute of Allergy and Infectious Diseases

15:50-16:10 | Global vaccinations and the antipoverty vaccines science vs antiscience | Dr. Peter Hotez - Baylor College of Medicine - Virtual 

16:10-16:15 | Q&A

16:15-16:35 | Involvement of phospholipase A2 group 4C induced by hepatitis C virus infection in hepatic lipid accumulation | Dr. Tadaki Suzuki - National Institute of Infectious Diseases

16:35-16:40 | Q&A

16:40-17:00 | Rotavirus replication and pathogenesis | Dr. Takeshi Kobayashi - Osaka University 

17:00-17:05 | Q&A

17:05-17:25 | What makes an effective live-attenuated vaccine? New insights into the innate cellular response to yellow fever virus 17D (YFV-17D) | Dr. Sonja M. Best - National Institute of Allergy and Infectious Diseases

17:25-17:30 | Q&A

17:30-17:50 | Functional characteristics of SARS-CoV-2-specific memory CD8+ T cells | Eui-Cheol Shin - Korea Advance Institute of Science and Technology

17:50-17:55 | Q&A

17:55-18:00 | Announcements 

_______________________________________________________________

Wednesday | 6 March 2024 | DAY TWO

_______________________________________________________________

SESSION FOUR: Epidemiology and Surveillance

Moderators: Dr. Thomas Hope - Northwestern University & Dr. Mo-Ran Ki, National Cancer Center 

Rapporteurs: Dr. Erik Stemmy - National Institute of Allergy and Infectious Diseases & Dr. Karl Salzwedel, National Institute of Allergy and Infectious Diseases

8:00-8:20 | Statistical genetics elucidates biology and medicine of infectious diseases | Dr. Yukinori Okada - Osaka University

8:20-8:25 | Q&A

8:25-8:45 | Modeling clade I mpox lesion transition dynamics A retrospective analysis of clinical data in DRC | Dr. Shingo Iwami - Nagoya University

8:45-8:50 | Q&A

8:50-9:10 | Pandemic Preparedness — The PREMISE Program | Dr. Danny Douek - National Institiute of Allergy and Infectious Diseases

9:10-9:15 | Q&A

9:15-9:35 | Rapid Real-World Evidence Generation using South Korea's Database in the COVID-19 era | Dr. Jae-Hun Jung - Gachon University

9:35-9:40 | Q&A

9:40-10:00 | Mpox | Dr. Anne Rimoin - University of California, Los Angeles (Virtual)

10:00-10:05 | Q&A

_______________________________________________________________

10:05-10:20 | Coffee Break 

_______________________________________________________________

SESSION FIVE: Factors Affecting Virus Emergence and Expansion

Moderators: Dr. Akira Nishizono - Oita University & Dr. Jorge Vidal - University of Mississippi

Rapporteurs: Dr. Masaya Sugiyama - National Center for Global Health and Medicine & Dr. Eun-Chung Park - National Institute of Allergy and Infectious Diseases

10:20-10:40 | Understanding the molecular mechanism of membrane dynamics-associated Ebola virus particle formation | Dr. Asuka Nanbo | Nagasaki University

10:40-10:45 | Q&A

10:45-11:05 | High exposure to Bas-Congo virus among Mangala residents 13 years after the Bas-Congo virus-associated acute hemorrhagic fever outbreak in the Democratic Republic of the Congo | Dr. Ayato Takada - Hokkaido University 

11:05-11:10 | Q&A

11:10-11:30 | Severe Fever with Thrombocytopenia Syndrome (SFTS) in South | Dr. Sang Won Park - Seoul National University 

11:30-11:35 | Q&A

11:35-11:55 | Factors driving the emerging bat zoonotic virus spillover | Dr. Linfa Wang - Duke-NUS Medical School - Virtual

11:55-12:00 | Q&A

12:00-12:20 | Polymicrobial Interactions Operative During Pathogen Transmission | Dr. Jason Rosch - St. Jude Children's Research Hospital

12:20-12:25 | Q&A

_______________________________________________________________

12:25-14:00 | Lunch Break and Poster Session

_______________________________________________________________

SESSION SIX: Strategies for Virus Elimination 

Moderators: Dr. Takaori-Kondo Akifumi - Kyoto University Hospital & Dr. Don-Gun Lee - The Catholic University of Korea

Rapporteurs: Dr. Karl Salzwedel - National Institutes of Allergy and Infectious Diseases & Dr. Eun-Chung Park - National Institute of Allergy and Infectious Diseases

14:00-14:20 | Strategies for HCV elimination in Japan: Achievement and challenges assessed by performance indicators. | Dr. Tetsuya Kanto - National Center for Global Health and Medicine 

14:20-14:25 | Q&A

14:25-14:45 | Evasion of APOBEC1-mediated Intrinsic Immunity by a Herpesvirus Uracil DNA Glycosylase Is a Determinant of Viral Encephalitis | Dr. Yasushi Kawaguchi - The University of Tokyo

14:45-14:50 | Q&A

14:40-15:10 | Current Landscape and National Strategies for Viral Hepatitis in South Korea | Dr. Sook-Hyang Jeong - Seoul National University Bundang Hospital

15:10-15:15 | Q&A

15:15-15:35 | Sustaining measles and rubella elimination and poliomyelitis eradication status in the Republic of Korea | Dr. Jin Gwack - Jeonbuk National University 

15:35-15:40 | Q&A

_______________________________________________________________

15:40-15:55 | Break 

_______________________________________________________________

SESSION SEVEN: Clinical Management 

Moderators: Dr. Yohei Doi - Fujita Health University + University of Pittsburgh School of Medicine & Dr. Hee-Chang Jang, National Institute of Infectious Diseases

Rapporteurs: Dr. Marie Ricciardone - National Cancer Institute

15:55-16:15 | Emergency Preparedness in Clinical Laboratories: Lessons Learned from COVID-19 | Dr. Miki Nagao - Kyoto University

16:15-16:20 | Q&A

16:20-16:40 | COVID-19 clinical trials in Japan | Dr. Yohei Doi - Fujita Health University and University of Pittsburgh School of Medicine

16:40-16:45 | Q&A

16:45-17:05 | Respiratory syncytial virus infection and management in high-risk patients | Dr. YaeJean Kim - Samsung Medical Center in Seoul

17:05-17:10 | Q&A

17:10-17:30 | Viral shedding kinetics in patients with SARS-CoV-2 infection | Dr. Sung-Han Kim - Asan Medical Center

17:30-17:35 | Q&A

17:35-17:55 | Advancing Clinical Management of Influenza Through AI-Driven Diagnostics and Prediction | Dr. Kuan-Fu Chen - Chang Gung University

17:55-18:00 | Q&A

18:00-18:05 | Closing Remarks

_______________________________________________________________